International Keratoconus Academy Symposium: What to expect

Video

CEO and cofounder of the International Keratoconus Academy S. Barry Eiden, OD, FAAO, FSLS, sits down to discuss the inaugural symposium, which will be held April 22-23, 2023, in Scottsdale, Arizona.

Video transcript

Kaiser:

Hi, everyone. I'm Emily Kaiser with Optometry Times. And I'm sitting down with Dr. Barry Eiden, who's the CEO and cofounder of the International Keratoconus Academy, or IKA, and is the cochair of the inaugural IKA meeting in Scottsdale, Arizona, in April of 2023. Welcome, Dr. Eiden! Thank you for taking the time to talk to us.

Eiden:

Thank you. Thank you so much.

Kaiser:

So what can clinicians expect from this inaugural meeting?

Eiden:

Well, I think it's going to be amazingly exciting. It's, it's kind of one of its kind, dedicated purely to the topic of keratoconus. And I think that it will really have value for eye care practitioners of all levels: Those who are just getting into the topic of keratoconus and to those who have had years and years of experience. So, I think it's going to be highly valuable for a wide variety of individuals.

Kaiser:

Yeah, absolutely. And what sets the IKA meeting apart from other conferences?

Eiden:

Well, I think there's a couple of factors. Number one, is focus: the fact that it is purely a keratoconus meeting. It's not trying to cover all aspects of the cornea or other areas of eye care. It's really laser focused, so to speak, on the cornea.

The second thing is the faculty that we're going to have at this particular meeting. These are going to be basically the who's who of keratoconus worldwide, both from optometry, ophthalmology and other allied health professional areas.

Third one; thirdly, it's going to give the opportunity for individuals to have a lot of interactive time together and share their thoughts and experiences. So I think it's going to be an amazing time for those who attend.

Kaiser:

I agree; it sounds so incredible. And what are you most excited to share with attendees?

Eiden:

What makes me very excited and the things that I really hope that our attendees get out of the meeting, whether they're attending live, which we hope they will, or virtually, since we'll have both options available, and that is the ability to get the most current information on the state-of-the-art in both diagnosis and treatment of this disease, which we now know, is so much more common than we ever thought before.

Kaiser:

Is there anything else that you'd like to mention that we haven't touched on?

Eiden:

Well, I would say there are a number of aspects in my judgment that make a meeting really worthwhile to go to. Number one would be the content. And I think we're going to have absolutely first-rate content. The second is value. You know, today, you can get your continuing education in so many different forms. So going to a live meeting, involving travel and such, you want to be in a good place. And Scottsdale in April is a pretty darn good place. I think we've chosen a fabulous location and facility for this particular meeting. And then finally, again, what excites me the most are the people who are going to be there, those who are going to present and I believe also those who are going to attend. I think it's going to be just a fantastic experience.

Kaiser:

All right. Well, thank you so much for taking the time to talk to me, and I can't wait to see you in Scottsdale!

Eiden:

Thanks so much.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
© 2024 MJH Life Sciences

All rights reserved.